Abstract not availableNicholas I. Fleming, Robert N. Jorissen, Dmitri Mouradov, Michael Christie, Anuratha Sakthianandeswaren, Michelle Palmieri, Fiona Day, Shan Li, Cary Tsui, Lara Lipton, Jayesh Desai, Ian T. Jones, Stephen McLaughlin, Robyn L. Ward, Nicholas J. Hawkins, Andrew R. Ruszkiewicz, James Moore, Hong-Jian Zhu, John M. Mariadason, Antony W. Burgess, Dana Busam, Qi Zhao, Robert L. Strausberg, Peter Gibbs, and Oliver M. Siebe
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
The SMAD4 tumor suppressor gene product inhibits transforming growth factor-β-mediated signaling and...
SMAD4 is an essential mediator in the transforming growth factor-β pathway. Sporadic mutations of SM...
Fulltext embargoed for: 12 months post date of publicationActivation of the canonical TGF-β signalin...
In colorectal cancer (CRC), inactivation of SMAD4 occurs early in the disease development and SMAD4 ...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Smad4 is an essential signal transducer of the transforming growth factor beta (TGF-beta) signalling...
Smad4 is an essential signal transducer of the transforming growth factor beta (TGF-beta) signalling...
Background and aims: Loss of DNA sequences from chromosome 18q21 is a major genetic change in colore...
Abstract Background Approximately 5.0–24.2% of colorectal cancers (CRCs) have inactivating mutations...
Colorectal cancer (CRC) is one of the leading cancers throughout the world. It represents the third ...
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
The SMAD4 tumor suppressor gene product inhibits transforming growth factor-β-mediated signaling and...
SMAD4 is an essential mediator in the transforming growth factor-β pathway. Sporadic mutations of SM...
Fulltext embargoed for: 12 months post date of publicationActivation of the canonical TGF-β signalin...
In colorectal cancer (CRC), inactivation of SMAD4 occurs early in the disease development and SMAD4 ...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Objective: Chromosomal loss within the region of 18q and loss of SMAD4 expression have been reported...
Smad4 is an essential signal transducer of the transforming growth factor beta (TGF-beta) signalling...
Smad4 is an essential signal transducer of the transforming growth factor beta (TGF-beta) signalling...
Background and aims: Loss of DNA sequences from chromosome 18q21 is a major genetic change in colore...
Abstract Background Approximately 5.0–24.2% of colorectal cancers (CRCs) have inactivating mutations...
Colorectal cancer (CRC) is one of the leading cancers throughout the world. It represents the third ...
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
Background/Aims: Loss of Smad4 function is associated with the acquisition of advanced colorectal ca...
The SMAD4 tumor suppressor gene product inhibits transforming growth factor-β-mediated signaling and...